Research output per year
Research output per year
Personal profile
Fields of Science
- 3111 Biomedicine
International and National Collaboration
Publications and projects within past five years.
-
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
Murumägi, A., Ungureanu, D., Khan, S., Arjama, M., Välimäki, K., Ianevski, A., Ianevski, P., Bergstrom, R., Dini, A., Kanerva, A., Koivisto-Korander, R., Tapper, J., Lassus, H., Loukovaara, M., Mägi, A., Hirasawa, A., Aoki, D., Pietiäinen, V., Pellinen, T., Butzow, R., & 2 others, 16 Feb 2023, In: British Journal of Cancer. 128, 4, p. 678–690 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features
Pellinen, T., Paavolainen, L., Martin-Bernabe, A., Araujo, R. P., Strell, C., Mezheyeuski, A., Backman, M., La Fleur, L., Brück, O., Sjolund, J., Holmberg, E., Välimäki, K., Brunnström, H., Botling, J., Moreno-Ruiz, P., Kallioniemi, O., Micke, P. & Östman, A., 10 Jan 2023, In: Journal of the National Cancer Institute. 115, 1, p. 71–82 12 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Immunohistokemialliset monivärjäykset kudostutkimuksessa : diagnostiikan arkipäivää ja tulevaisuutta
Väyrynen, J., Väyrynen, S., Ollila-Raj, H., Pellinen, T. & Mirtti, T., 2023, In: Duodecim. 139, 7, p. 531-540 10 p.Research output: Contribution to journal › Review Article › peer-review
-
Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing
Ollila-Raj, H., Murumägi, A., Pellinen, T., Arjama, M., Sutinen, E., Volmonen, K., Haikala, H. M., Kallioniemi, O., Mäyränpää, M. I. & Ilonen, I., Apr 2023, In: Lung Cancer. 178, p. 213-219 7 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity
Piki, E., Dini, A., Raivola, J., Salokas, K., Zhang, K., Varjosalo, M., Pellinen, T., Välimäki, K., Veskimäe, K. T., Staff, S., Hautaniemi, S., Murumägi, A. & Ungureanu, D., 3 Jul 2023, In: Cell death discovery . 9, 1, 10 p., 222.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
-
Juselius 2023/ Pan Cancer Spatial Image
01/05/2023 → 30/04/2024
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Kallioniemi / Juselius 2023 - 2026
Kallioniemi, O. & Pellinen, T.
01/05/2023 → 30/04/2024
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Syöpäs 2023-25 Pellinen
Syöpäsäätiö sr Cancerstiftelsen sr
01/01/2023 → 31/12/2024
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Prizes
-
Elias Tillandz best scientific article Turku
Pellinen, Teijo (Recipient), 12 Aug 2008
Prize: Prizes and awards
-
Activities
-
Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital
Teijo Pellinen (Visiting researcher)
1 Sep 2016 → 31 Dec 2017Activity: Visiting an external institution types › Academic visit to other institution
-
AACR Annual Meeting 2015
Teijo Pellinen (Poster Presentation)
18 Apr 2015Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
Supervision of technician
Teijo Pellinen (Participant)
2014 → 2016Activity: Other activity types › Types for other activities - Other
-
Supervision of technician
Teijo Pellinen (Participant)
2014 → 2016Activity: Other activity types › Types for other activities - Other
-
Doctoral thesis supervision
Teijo Pellinen (Supervisor)
2012 → 27 Sep 2019Activity: Examination types › Supervisor or co-supervisor of doctoral thesis